Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × NETWORK × binimetinib × Clear all

Phase

Status

Terminated 1 Active not recruiting 1

Sponsor Class

OTHER 7 INDUSTRY 4 NIH 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 14 Magnetic Resonance Spectroscopy 14 Cyclophosphamide 14 Vincristine 13 Radiotherapy 12 Dexamethasone 12 Cisplatin 12 Carboplatin 12 Etoposide 11 Radiation 10 durvalumab 9 Paclitaxel 9 Doxorubicin 9 Temozolomide 7 Radiotherapy, Intensity-Modulated 7 Lenalidomide 7 Irinotecan 7 Fluorouracil 7 Docetaxel 7 Cytarabine 7 daratumumab 6 Prednisone 6 Platinum 6 Leucovorin 6 Capecitabine 6 Bortezomib 6 Biopsy 6 tremelimumab 5 dehydroftorafur 5 Watchful Waiting 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03235245 2025-08-01

EBIN

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡